Clinical Trial Update: Namenda to Prevent Post-Operative Delirium [Phase 4]

View source ↗

Summary

Phase 4 trial of memantine (Namenda) to prevent postoperative delirium has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Postoperative Delirium

Drugs mentioned

• Namenda (memantine)

Snippet

Sponsor: University of Rochester | Conditions: Delirium, Post-Operative States | Phase 4 | Status: TERMINATED